Cargando…
Clinical utility of secukinumab in moderate-to-severe scalp psoriasis: evidence to date
Psoriasis is an immune-mediated inflammatory dermatosis commonly affecting the scalp and fringes of the face, neck and ears. It may be difficult to treat and the presence of extensive and highly visible lesions may significantly influence psychosocial well-being. Secukinumab, a monoclonal antibody t...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6498391/ https://www.ncbi.nlm.nih.gov/pubmed/31118728 http://dx.doi.org/10.2147/CCID.S165040 |